Cargando…
P21. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention
Autores principales: | Prinz, P, Noessner, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072099/ http://dx.doi.org/10.1186/2051-1426-2-S2-P12 |
Ejemplares similares
-
P31. Genomic profiling and functional characterisation of a new myeloid cell type enriched in renal cell carcinoma
por: Brech, D, et al.
Publicado: (2014) -
Promoting NK cell trafficking to improve therapeutic effect of NK cell therapy on osteosarcoma
por: Yang, Yuanzheng, et al.
Publicado: (2015) -
Renal targeted protein therapeutics in experimental overt heart failure with renal dysfunction
por: Chen, Horng H, et al.
Publicado: (2009) -
P72. Transgenic expression of a chimeric signaling receptor to facilitate T cell costimulation in the tumour environment
por: Schlenker, R, et al.
Publicado: (2014) -
P33. NK-92 cellular immunotherapy as an alternative to donor derived peripheral blood NK cells
por: Klingemann, H
Publicado: (2014)